BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4408234)

  • 1. Inhibition of leucocyte migration in man by the agarose plate technique using protein purified derivatives (PPD) from three different sources.
    Passaleva A; Forti A; Ricci M
    Acta Allergol; 1974 Jun; 29(3):209-21. PubMed ID: 4408234
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of PPD and BCG-induced leukocyte migration inhibition, delayed cutaneous hypersensitivity, lymphocyte transformation in vitro and humoral antibodies to PPD in man.
    Fleer A; van der Hart M; Blok-Schut BJ; Schellekens PT
    Eur J Immunol; 1976 Mar; 6(3):163-7. PubMed ID: 791653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The agarose migration inhibition technique for in vitro demonstration of cell-mediated immunity in man. A review.
    Clausen JE
    Dan Med Bull; 1975 Jul; 22(5):181-94. PubMed ID: 126141
    [No Abstract]   [Full Text] [Related]  

  • 5. Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
    McCoy JL; Dean JH; Herberman RB
    J Immunol Methods; 1977; 15(4):355-71. PubMed ID: 874326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of delayed hypersensitivity in the human. Inhibition of cell migration from agarose microdroplets.
    Lavergne JA; Harrington JT
    J Immunol Methods; 1978; 22(1-2):111-21. PubMed ID: 670720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation-inducing factors from human lymphocytes. Correlation with polymorphonuclear leucocyte migration enhancement of inhibition.
    Warrington RJ; Buehler SK; Roberts KB
    Int Arch Allergy Appl Immunol; 1976; 51(2):186-97. PubMed ID: 1279021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis.
    Frei PC; Erard P; Zinkernagel R
    Biomedicine; 1973 Sep; 19(9):379-83. PubMed ID: 4791976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of cellular sensitization to BCG and PPD using leukocyte cell migration inhibition].
    Lenzini L; Rottoli L; Rottoli P
    Ann Sclavo; 1975 SEP-OCT; 17(5):660-7. PubMed ID: 782381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte migration inhibition in diphtheria toxoid hypersensitivity.
    Saxby MF; Salaman MR; Sargent IL
    Allergy; 1987 Aug; 42(6):473-6. PubMed ID: 3310718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucocyte migration test in agarose. The use of puromycin in disclosure of non-immunological inhibition.
    Mygind K; Stenbjerg S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):277-82. PubMed ID: 4527885
    [No Abstract]   [Full Text] [Related]  

  • 12. A micro-method for peripheral leucocyte migration in tuberculin sensitivity.
    Federlin K; Maini RN; Russell AS; Dumonde DC
    J Clin Pathol; 1971 Sep; 24(6):533-6. PubMed ID: 5094689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine spleen leukocytes as an inhibitable target cell system for human MIF.
    Górski AJ
    Cell Immunol; 1974 May; 12(2):315-22. PubMed ID: 4617631
    [No Abstract]   [Full Text] [Related]  

  • 14. Technical study of the leucocyte migration inhibition test in agarose. Application to PPD and to hepatitis B antigen.
    Erard P
    Clin Exp Immunol; 1974 Nov; 18(3):439-48. PubMed ID: 4619978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocyte migration inhibition test and tuberculin hypersensitivity. "Escape" and some other factors influencing the clinical use.
    Sabioncello A; Dekaris D
    Allergy; 1980 Mar; 35(2):123-33. PubMed ID: 7386799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation.
    Repo H; Kostiala AA; Kosunen TU
    Clin Exp Immunol; 1980 Feb; 39(2):442-8. PubMed ID: 6993072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the inhibition of leucocyte migration and monocyte spreading as in vitro assays for tuberculin hypersensitivity in man.
    Silobrcić V; Sabioncello A; Mazuran R; Dekaris D; Kadrnka-Lovrencić M
    Clin Exp Immunol; 1975 May; 20(2):239-47. PubMed ID: 813926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of delayed hypersensitivity, lymphocyte transformation and leucocyte migration inhibition by M. xenopi and M. tuberculosis in patients harbouring these organisms.
    Maini RN; Beck A; Roffe L
    Tubercle; 1974 Dec; 55(4):269-81. PubMed ID: 4220081
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the leucocyte migration test as a measure of delayed hypersensitivty in man. Suppression of migration inhibition by puromycin.
    Mitchell CG; Smith MG; Golding PL; Eddleston AL; Williams R
    Clin Exp Immunol; 1972 Aug; 11(4):535-41. PubMed ID: 5085243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte migration inhibition by dental plaque antigens as indicated by the capillary tube and the agarose plate technique.
    Budtz-Jörgensen E; Kelstrup J; Budtz-Jörgensen A
    J Periodontal Res; 1976 Apr; 11(2):86-95. PubMed ID: 132521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.